Article
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients
Author/s | Trujillo-Rodriguez, Maria
Muñoz Muela, Esperanza Serna Gallego, Ana Praena Fernández, Juan Manuel Pérez Gómez, Alberto Gasca-Capote, Carmen López Cortés, Luis Fernando |
Department | Universidad de Sevilla. Departamento de Medicina |
Publication Date | 2022-07-14 |
Deposit Date | 2023-05-25 |
Published in |
|
Abstract | Background
The SARS-CoV-2 pandemic has overwhelmed hospital services due to the rapid transmission of the virus and its severity in a high percentage of cases. Having tools to predict which patients can be safely early ... Background The SARS-CoV-2 pandemic has overwhelmed hospital services due to the rapid transmission of the virus and its severity in a high percentage of cases. Having tools to predict which patients can be safely early discharged would help to improve this situation. Methods Patients confirmed as SARS-CoV-2 infection from four Spanish hospitals. Clinical, demographic, laboratory data and plasma samples were collected at admission. The patients were classified into mild and severe/critical groups according to 4-point ordinal categories based on oxygen therapy requirements. Logistic regression models were performed in mild patients with only clinical and routine laboratory parameters and adding plasma pro-inflammatory cytokine levels to predict both early discharge and worsening. Results 333 patients were included. At admission, 307 patients were classified as mild patients. Age, oxygen saturation, Lactate Dehydrogenase, D-dimers, neutrophil-lymphocyte ratio (NLR), and oral corticosteroids treatment were predictors of early discharge (area under curve (AUC), 0.786; sensitivity (SE) 68.5%; specificity (S), 74.5%; positive predictive value (PPV), 74.4%; and negative predictive value (NPV), 68.9%). When cytokines were included, lower interferon-γ-inducible protein 10 and higher Interleukin 1 beta levels were associated with early discharge (AUC, 0.819; SE, 91.7%; S, 56.6%; PPV, 69.3%; and NPV, 86.5%). The model to predict worsening included male sex, oxygen saturation, no corticosteroids treatment, C-reactive protein and Nod-like receptor as independent factors (AUC, 0.903; SE, 97.1%; S, 68.8%; PPV, 30.4%; and NPV, 99.4%). The model was slightly improved by including the determinations of interleukine-8, Macrophage inflammatory protein-1 beta and soluble IL-2Rα (CD25) (AUC, 0.952; SE, 97.1%; S, 98.1%; PPV, 82.7%; and NPV, 99.6%). Conclusions Clinical and routine laboratory data at admission strongly predict non-worsening during the first two weeks; therefore, these variables could help identify those patients who do not need a long hospitalization and improve hospital overcrowding. Determination of pro-inflammatory cytokines moderately improves these predictive capacities. |
Funding agencies | Consejería de Salud y Familia Consejería de Transformación Económica, Industria, Conocimiento y Universidades Instituto de Salud Carlos III |
Project ID. | RH-0037-2020 a JV
PY20/01276 a APG CP19/00159 a AGV CP19/00146 a AR FI19/00304 a EMM FI19/00083 MCGC,RD16/0025/0020 RD16/0025/0006 RD16/0025/0026 CB21/13/00020 |
Citation | Trujillo-Rodriguez, M., Muñoz Muela, E., Serna Gallego, A., Praena Fernández, J.M., Pérez Gómez, A., Gasca-Capote, C. y López Cortés, L.F. (2022). Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients. PLoS ONE, 17 (7), e0269875. https://doi.org/10.1371/journal.pone.0269875. |
Files | Size | Format | View | Description |
---|---|---|---|---|
Clinical, laboratory data and ... | 1.433Mb | [PDF] | View/ | |